ADPT
Adaptive Biotechnologies Corp
NASDAQ: ADPT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$13.54
-6.53% today
Updated 2026-06-05
Market cap
$2.82B
P/E ratio
—
P/S ratio
9.54x
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$10 – $21
Volume
1.8M
Adaptive Biotechnologies Corp (ADPT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$13.54
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$31.45
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -16.80%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.